Welcome to a Symposium specifically developed for patients, families, and caregivers.
The C. diff. Patient, Family, Caregiver Symposium will be a gathering of healthcare professional keynote speakers, health advocates, practitioners, educators, thought leaders, and patients who are transforming the patient experience, and changing the way people experience C. diff. infections worldwide
Our distinguished members and keynote speakers will provide insight as to what impacts the patient and families on both quality and economic topics, what role leadership plays in creating the right culture for patient-centered care, and how to identify, evaluate, and prioritize innovations that can quickly touch the lives of patients battling C. diff. infections.
Unlike other conferences on this topic, patients will share their C. diff. infection journeys, providing a real-world perspective on patient experience. Our attendees will learn more from this virtual-online symposium and gain knowledge on important topics that will better aid their care and recovery through tools and strategies delivered by keynote speakers.
C Diff Foundation Mission statement – Educating and Advocating for the prevention, treatments, clinical trials, diagnostics, and environmental safety of Clostridioides difficile (C. diff.) infections worldwide.
Keynote speakers will present up-to-date data to expand on the existing knowledge and provide important information focused on, yet not limited to, a Clostridiioides difficile infection (also known as C. diff., C. difficile, CDAD, CDI) —
- Environmental Safety
- Clinical trials and studies
- Introduction to Microbiome Research and Studies
- Infection Prevention
- Fecal Microbiota Restoration and Transplants
Symposium Registration is free of charge and completely online.
Guest speaker audio and/or visual can be accessed by a computer. Registration is easy. Please click on the RED button below.
Dale Gerding, MD – Online-Live Symposium Chair.
1:00 Seres Therapeutics Treatment of recurrent C. difficile infection with SER-109, an investigational microbiome drug.
1:15 Sahil Khanna, MBBS C. diff. and Fecal Microbiota Transplants
1:30 Stuart Johnson, MD C. diff. Treatment Options
1:45 Dale Gerding, MD C. diff. Overview
2:00 Larry Kociolek, MD C. diff. Infections in Pediatrics
2:15 Dave Bischoff C. diff. Transitioning from Hospital to Home
2:30 Renata Johnson Microbiome, Microbiota, and Gut Health.
2:45 Closing Comments Review